碳酸锂配合131I治疗低摄碘率甲状腺功能亢进

    Lithium carbonate plus 131I for treatment of low iodine uptake in hyperthyroidism

    • 摘要: 目的:观察碳酸锂对甲状腺摄碘率(radioactive iodineup take,RAIU)的影响,探讨碳酸锂配合131I治疗低摄碘率Graves'病患者的临床疗效。方法:对36例RAIU<50%的Graves'病患者,给予碳酸锂0.25g口服,每天3次,共7天,测定RAIU,根据RAIU的变化,比较服用131I剂量的差别。结果:36例在服用碳酸锂后,最高RAIU由(45.58±4.01)%上升至(64.36±4.66)%,有统计学意义(P<0.001),服锂前平均需服131I量为(991.6±577.2)MBq,服锂后降至(503.2±288.6)MBq。结论:碳酸锂能够提高Graves'病患者的RAIU,从而使部分不适合131I治疗的患者可能采用131I治疗,并在一定程度上减少了放射性131I的治疗用量。

       

      Abstract: Objective: To observe the influence of lithium carbonate on thyroid radioactive iodine uptake(RAIU) and to investigate the effects of the therapy of lithium carbonate plus radioiodine on low thyroid iodine uptake in Graves's patients.Methods: Thirty-six hyperthyroidism patients with RAIU<50% were orally administered lithium carbonate 0.25 g,3 times per day for 7 days.The thyroid RAIU rate was detected before and after treatment,and the dosages of 131I needed by the patients were varied in accordance with the RAIU rate.Results: After lithium carbonate therapy,the thyroid RAIU in 36 cases increased from(45.58±4.01)% to(64.36±4.66)% and the dosage of 131I needed by patients decreased from(991.6±577.2) MBq to(503.2±288.6) MBq.The difference was significant(P<0.001).Conclusions: Lithium carbonate can increase the thyroid RAIU in Graves'patients,which enables the patients with low thyroid RAIU to receive 131I therapy;and the dosage of 131I is also decreased to some degree.

       

    /

    返回文章
    返回